“Pharma’s Nonobvious Problem”

  • Intellectual Property and Antitrust
Lewis and Clark Law Review
2008

“Noncompliance, Nonenforcement, Nonproblem? Rethinking the Anticommons in Biomedical Research”

  • Intellectual Property and Antitrust
Houston Law Review
2008

“Technocracy and Antitrust”

  • Intellectual Property and Antitrust
Texas Law Review
2008

“Antitrust Enforcement During National Crises: An Unhappy History”

  • Intellectual Property and Antitrust
Competition Policy International Antitrust Chronicle
2008

“The Supreme Court and the Federal Circuit: Visitation and Custody of Patent Law”

  • Intellectual Property and Antitrust
Michigan Law Review First Impressions
2007

“The Role of the FDA in Innovation Policy”

  • Intellectual Property and Antitrust
Michigan Telecommunications and Technology Law Review
2007

“Rules versus Standards in Antitrust Adjudication”

  • Intellectual Property and Antitrust
Washington and Lee Law Review
2007

“Harnessing and Sharing the Benefits of State-Sponsored Research: Intellectual Property Rights and Data Sharing in California’s Stem Cell Initiative”

  • Intellectual Property and Antitrust
Berkeley Technology Law Journal
2006

“BioTech. Patents: Looking Backward While Moving Forward”

  • Intellectual Property and Antitrust
Nature Biotechnology
2006

“Mixed Bundling, Profit Sacrifice, and Consumer Welfare”

  • Intellectual Property and Antitrust
Emory Law Journal
2006

“Patents and Data-Sharing in Public Science”

  • Intellectual Property and Antitrust
Industrial and Corporate Change
2006

“Damages for Exclusionary Bundled Discounts”

  • Intellectual Property and Antitrust
Antitrust Bulletin
2006

“The Paradox of Predatory Pricing”

  • Intellectual Property and Antitrust
Cornell Law Review
2005

“Harmful Output in the Antitrust Domain: Lessons from the Tobacco Industry”

  • Intellectual Property and Antitrust
Georgia Law Review
2005

“Multiproduct Discounting A Myth of Nonprice Predation”

  • Intellectual Property and Antitrust
University of Chicago Law Review
2005

“The Perverse Effects of Predatory Pricing Law”

  • Intellectual Property and Antitrust
Regulation
2005

“Ease Over Accuracy in Assessing Patent Settlements”

  • Intellectual Property and Antitrust
Minnesota Law Review
2004

“Obvious to Whom? Evaluating Inventions from the Perspective of PHOSITA”

  • Intellectual Property and Antitrust
Berkeley Technology Law Journal
2004

“Patenting Genome Research Tools and the Law”

  • Intellectual Property and Antitrust
Comptes rendus Biologies
2003

“Patent Swords and Shields”

  • Intellectual Property and Antitrust
Science
2003

“Patents, Product Exclusivity, and Information Dissemination: How Law Directs Biopharmaceutical Research and Development”

  • Intellectual Property and Antitrust
Fordham Law Review
2003

“Bayh-Dole Reform and the Progress of Biomedicine”

  • Intellectual Property and Antitrust
Law and Contemporary Problems
2003

“Bayh-Dole Reform and the Progress of Biomedicine”

  • Intellectual Property and Antitrust
American Scientist
2003

“How Can You Patent Genes?”

  • Intellectual Property and Antitrust
American Journal of Bioethics
2002

“Public vs. Proprietary Science: A Fruitful Tension?”

  • Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002

“Why the Gene Patenting Controversy Persists”

  • Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002

“Public vs. Proprietary Science: A Fruitful Tension?”

  • Intellectual Property and Antitrust
Daedalus
2002

“Exit Payments in Settlement of Patent Infringement Lawsuits: Antitrust Rules and Economic Implications”

  • Intellectual Property and Antitrust
Florida Law Review
2002

“The Shifting Functional Balance of Patents and Drug Regulation”

  • Intellectual Property and Antitrust
Health Affairs
2001

“Analyze This: A Law and Economics Agenda for the Patent System”

  • Intellectual Property and Antitrust
Vanderbilt Law Review
2000

“Re-Examining the Role of Patents in Appropriating the Value of DNA Sequences”

  • Intellectual Property and Antitrust
Emory Law Journal
2000

“Genomics in the Public Domain: Strategy and Policy”

  • Intellectual Property and Antitrust
Nature Reviews Genetics
2000

“The Promise and Perils of Strategic Publication to Create Prior Art: A Response to Professor Parchomovsky”

  • Intellectual Property and Antitrust
Michigan Law Review
2000

“Faith, Reason, and Bare Animosity”

  • Intellectual Property and Antitrust
Campbell Law Review
1999

“National Policy Perspectives-Streamlining the Transfer of Research Tools”

  • Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
1999

“Can Patents Deter Innovation? The Anticommons on Biomedical Research”

  • Intellectual Property and Antitrust
Science
1998

“Upstream Patents = Downstream Bottlenecks”

  • Intellectual Property and Antitrust
Law Quadrangle Notes
1998

“Do EST Patents Matter?”

  • Intellectual Property and Antitrust
Trends in Genetics
1998

“Structure and Function in Gene Patenting”

  • Intellectual Property and Antitrust
Nature Genetics
1997

“Public Research and Private Development: Patents and Technology Transfer in Government-Sponsored Research”

  • Intellectual Property and Antitrust
Virginia Law Review
1996

“Intellectual Property at the Public-Private Divide: The Case of Large-Scale cDNA Sequencing”

  • Intellectual Property and Antitrust
University of Chicago Law School Roundtable
1996

“Intellectual Property Issues in Genomics”

  • Intellectual Property and Antitrust
Trends in Biotechnology
1996

“Opinion Letter as to the Patentability of Certain Inventions Associated with the Identification of Partial cDNA Sequences”

  • Intellectual Property and Antitrust
AIPLA Quarterly Journal
1995

“Reply to Comments on the Patentability of Certain Inventions Associated with the Identification of Partial cDNA Sequences”

  • Intellectual Property and Antitrust
AIPLA Quarterly Journal
1995

“Limiting the Role of Patents in Technology Transfer”

  • Intellectual Property and Antitrust
Law Quadrangle Notes
1994

“Technology Transfer and the Genome Project: Problems with Patenting Research Tools”

  • Intellectual Property and Antitrust
Risk: Health, Safety and Environment
1994

“A Technology Policy Perspective on the NIH Gene Patenting Controversy”

  • Intellectual Property and Antitrust
University of Pittsburgh Law Review
1994

“Limiting the Role of Patents in Technology Transfer”

  • Intellectual Property and Antitrust
Chemtech
1993

“Limiting the Role of Patents in Technology Transfer”

  • Intellectual Property and Antitrust
Journal of NIH Research
1993

“Symposium: Copyright Protection for Computer Databases, CD-ROMS and Factual Compilations”

  • Intellectual Property and Antitrust
University of Dayton Law Journal
1992